US20140065131A1 - Extract of a myceliated agricultural substrate and its use as a nutraceutical composition - Google Patents

Extract of a myceliated agricultural substrate and its use as a nutraceutical composition Download PDF

Info

Publication number
US20140065131A1
US20140065131A1 US13/874,832 US201313874832A US2014065131A1 US 20140065131 A1 US20140065131 A1 US 20140065131A1 US 201313874832 A US201313874832 A US 201313874832A US 2014065131 A1 US2014065131 A1 US 2014065131A1
Authority
US
United States
Prior art keywords
extract
substrate
agricultural substrate
group
aqueous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US13/874,832
Inventor
Brooks John Kelly
Jonathan Freestone Phillips
Jim Langan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mycotechnology Inc
Original Assignee
Mycotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mycotechnology Inc filed Critical Mycotechnology Inc
Priority to US13/874,832 priority Critical patent/US20140065131A1/en
Assigned to Mycotechnology, Inc. reassignment Mycotechnology, Inc. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KELLY, BROOKS J., DR., LANGAN, JIM, PHILIPS, JONATHAN FREESTONE
Assigned to Mycotechnology, Inc. reassignment Mycotechnology, Inc. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MYCOTECHNOLOGY INC.
Publication of US20140065131A1 publication Critical patent/US20140065131A1/en
Priority to JP2016503300A priority patent/JP6186070B2/en
Priority to SG11201507655RA priority patent/SG11201507655RA/en
Priority to BR112015023652-9A priority patent/BR112015023652B1/en
Priority to PCT/US2014/029998 priority patent/WO2014145265A2/en
Priority to EP14763975.1A priority patent/EP2986159B1/en
Priority to PCT/US2014/029989 priority patent/WO2014145256A1/en
Priority to SG11201507484YA priority patent/SG11201507484YA/en
Priority to KR1020187019060A priority patent/KR102087839B1/en
Priority to ES14763975T priority patent/ES2733912T3/en
Priority to EP19174384.8A priority patent/EP3560343A1/en
Priority to CN201480028249.1A priority patent/CN105682480B/en
Priority to KR1020157029425A priority patent/KR101786644B1/en
Priority to JP2016503304A priority patent/JP2016517280A/en
Priority to KR1020157029417A priority patent/KR20150131293A/en
Priority to AU2014233209A priority patent/AU2014233209B2/en
Priority to AU2014233200A priority patent/AU2014233200B2/en
Priority to CN201480028279.2A priority patent/CN105228462A/en
Priority to BR112015023468-2A priority patent/BR112015023468B1/en
Priority to EP14765389.3A priority patent/EP2986134B1/en
Assigned to Mycotechnology, Inc. reassignment Mycotechnology, Inc. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: KELLY, BROOKS JOHN, LANGAN, JAMES PATRICK
Priority to JP2017208402A priority patent/JP6518308B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A23L1/28
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L21/00Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L31/00Edible extracts or preparations of fungi; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L5/00Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23GCOCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30Cocoa products, e.g. chocolate; Substitutes therefor
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23GCOCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/32Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
    • A23G1/42Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23GCOCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G1/00Cocoa; Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/30Cocoa products, e.g. chocolate; Substitutes therefor
    • A23G1/32Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds
    • A23G1/42Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G1/423Cocoa products, e.g. chocolate; Substitutes therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing microorganisms, enzymes

Definitions

  • the present invention pertains to an extract of a myceliated agricultural substrate and its use as nutraceutical, food compositions and products.
  • Mycelium forms a vegetative part of a fungus consisting of a network of branched, tubular filaments referred to as hyphal structures.
  • the mycelial structures play a pivotal role in nutrient absorption by releasing enzymes into the substrate, including enzymes for breaking down complex organic polymers into simpler compounds which are absorbed through hyphal walls.
  • a fungal spore germinates into a monokaryotic mycelia and forms a dikaryotic mycelium on joining with other compatible mycelia and results in formation of fruiting bodies such as mushrooms.
  • Mycelium has been used as a primary source for medicinal extracts and animal food, while the fruiting bodies or mushrooms are generally used as human food.
  • Spore-bearing mushrooms and vegetative mycelia of edible and medicinal fungal species produce pharmacologically active metabolites including polysaccharides, proteins, glycoproteins, enzymes, glucans (alpha, beta), triterpenes, phenols and sterols.
  • compositions with potent health enhancing properties were isolated recently from medicinal mushrooms and distributed worldwide. Many of them are pharmaceutical products, while others represent a novel class of dietary supplements or “mushroom nutraceuticals”. For instance, antitumor polysaccharides, such as hetero- ⁇ -glucans and their protein complexes (e.g., xyloglucans, and acidic ( ⁇ -glucan containing uronic acid) as well as dietary fiber, lectins, and triterpenoids, have been isolated from medicinal mushrooms.
  • Nutraceutical compositions and food supplements with therapeutic activity produced from medicinal and edible mushrooms or fungi have been known in the art.
  • US Patent Publication US20050180989 discloses treatment of hyperlipemia by use of an antihyperlipidemic agent and food containing T. matsutake wherein T.
  • US Patent Publication US2006/0280753 discloses a composition and a method for obtaining a nutritional food product comprising a UV irradiated, fermented and dried mycelium/solid substrate mixture
  • US Patent Publication US2011/0091579 discloses production of vitamin D2 enriched mushrooms and fungi for treatment of oxidative stress, Alzheimer's disease
  • US Patent Publication US2011/0206721 discloses fermented soy nutritional supplements including mushroom components
  • WIPO publication WO2011/151831 discloses pharmaceutical compositions comprising extracts of Cyathus Striatus mushrooms.
  • Fungi are metabolically similar to animals but structurally similar to plants in that they possess a rigid cell wall formed largely of long sugar molecule chains joined by somewhat difficult to digest beta (b-) linkages and to a smaller extent more easily digestible alpha (a-) linkages in conjunction with membrane-bound proteins.
  • plant cell walls are made of cellulose polysaccharides whose 1->4 glycosidic Glucose linkages are likewise difficult to digest by our enzymes; however, as the cell walls of Fungi are primarily composed of 1->3 glycosidic linkages, with 1->6 linked side chains, they may be broken down by minimal processing using water, heat and mechanical treatment into smaller, more easily digestible, immunologically-active polysaccharide molecules of variable microparticulate size called b-glucans, and related glycoprotein compounds.
  • the immune response to Glucan is dependent upon a- or b-glucan structure, which has primary, secondary, and chiral tertiary structures, explaining the differences in immune response to each Fungi's unique a- and or b-glucan profile.
  • nutraceuticals should attract consumers who wish to derive the general immunomodulating, anti-aging, aphrodisiac, anti-tumour, anti-viral, anti-bacterial, and/or anti-fungal properties, activities, and benefits, by orally consuming substrates which has been converted to edible presentations of a- and b-glucans, glycoproteins, proteins, ergosterols, sterols, triterpenes, and fatty acids in the form of nutraceuticals formulations.
  • such new and better method of preparing an extract of myceliated agricultural material should be suitable for a variety of mycelial agricultural substrates in order to produce nutraceutical compositions with enhanced health benefits.
  • the present invention satisfies these unmet needs and generally overcomes the deficiencies prevalent in the art, by developing an extract of a myceliated agricultural substrate for use in formulating nutraceutical compositions, wherein the compositions offer a variety of health benefits including neuroregeneration and neuroprotection properties.
  • the present invention relates to an aqueous extract of a myceliated agricultural substrate for use as a nutraceutical or food composition for human consumption comprising at least one small molecule compound, wherein mycelia is grown on an agricultural substrate by inoculating the agricultural substrate with a pure strain of a fungal culture selected from a group comprising Basidiomycota and Ascomycota derived from a liquid fermentation, under optimum growth conditions, wherein the at least one small molecule compound enhances bioavailability, water solubility and passive absorption of the aqueous extract.
  • a small molecule compound can be selected from the group comprising citric acid, ascorbic acid, honey, cane sugar, grape fruit essential oil, citrus essential oil, ethyl alcohol and combinations thereof.
  • extract of a myceliated agricultural substrate of the present invention has neuroprotective and neuroregenerative properties, wherein fungi strains are selected from the group comprising Tremella fuciformis and Hericium erinaceus , further wherein the substrate is pre-processed before myceliation by at least partially coating the substrate with lecithin, vegetable oil or combinations thereof.
  • the present invention further provides a method of preparation of an aqueous extract of a myceliated agricultural substrate for use as a nutraceutical composition for human consumption, comprising the steps of
  • the present invention further provides a method for producing a nutraceutical composition with neuroprotective and neuroregenerative properties from an extract of a myceliated agricultural substrate comprising the steps of:
  • the at least one small molecule compound enhances bioavailability, water solubility and passive absorption of the aqueous extract.
  • the pre-processing step includes, but not limited to, for example at least partially coating a surface of the substrate with lecithin, vegetable oil or combinations thereof.
  • vegetable oil is olive oil.
  • the mycelia from strains of Basidiomycota and Ascomycota are grown in liquid-state culture and used to ferment solid-state agricultural substrates.
  • Nutraceutical or food composition of the present invention can further be in a form such as capsule, pill, tablet, syrup, drink mix, fluid, lozenge, powder and combinations thereof.
  • FIG. 1 is a flowchart of a method for preparing an extract of myceliated agricultural substrates.
  • FIG. 2 is a flowchart of a method of preparation of a nutraceutical or food composition from an extract of myceliated agricultural substrates.
  • the present invention provides an aqueous extract from a myceliated agricultural substrate for use in formulating nutraceutical and food compositions, wherein the compositions offer a variety of health benefits including neuroregeneration and neuroprotection properties.
  • Mycelium extracts have been shown to contain a variety of pharmacologically important compounds. Utilization of conventional pharmacological techniques of crystallizing or otherwise solidifying compounds of interest for delivery in pill form may diminish or destroy the effectiveness of the compounds by altering the macromolecular structure, generally done by chemically modifying polysaccharide structure, for example by way of Smith degradation, formolysis, and carboxymethylation. Pharmacological activity of these compounds depends on their molecular structure in solution.
  • the present invention provides mycelia extracts to the human body fit for oral ingestion in a water-soluble, unaltered form, by remaining in solution in association with small molecule compounds.
  • FIG. 1 shows a flow chart of a method of preparation of an extract from myceliated agricultural substrates wherein,
  • the present invention further provides a method of preparing a nutraceutical composition from an extract of myceliated agricultural substrates as shown in FIG. 2 , wherein,
  • optimum growth conditions for mycelial growth can be controlled by controlling parameters such as selective pH, temperature, humidity, incubation period, media composition, aeration and pressure among such other parameters.
  • Enabling of mycelia growth on a substrate can further comprise of maintaining liquid media under stationary condition or mixing the liquid media by utilizing mixing methods such as agitation, stirring, swirling continuously or intermittently among such other mixing methods.
  • the desired stage of mycelia growth can be reached, for example, when fruiting bodies begin to appear on a surface of an agricultural substrate.
  • the pre-processing step is selected from the group comprising:
  • aqueous component obtained after boiling a myceliated substrate with water, contains polysaccharides and other beneficial components suspended in water.
  • the non-aqueous component contains substrate solids. Separation of aqueous and non-aqueous components can be accomplished by methods such as filtering or siphoning or other methods known in the art.
  • the small molecule compound is selected from the group comprising citric acid, ascorbic acid, honey, cane sugar, grape fruit essential oil, citrus essential oil, ethyl alcohol and combinations thereof, wherein an addition of the small molecule compound facilitates water solubility, bioavailability and passive absorption of the aqueous extract.
  • the agricultural substrate is inoculated by liquid media comprising an aliquot of pure culture of a fungal strain selected from Basidiomycota and Ascomycota, wherein the fungal strains are derived from a liquid state fermentation.
  • the liquid media can be kept either stationary or non-stationary during liquid state fermentation.
  • the liquid media can be stationary creating a semi-anaerobic environment that enhances a direct mycelial growth downward from a floating mass into the liquid media.
  • the liquid media is mixed by methods such as agitation, swirling and stirring.
  • mycelia from strains selected from Basidiomycota and Ascomycota Fungi, is grown in liquid-state culture and used to ferment solid-state agricultural substrates.
  • liquid media can be injected with sterile air to deliver oxygen to the liquid media.
  • liquid state fermentation yields spherical conglomerations of culture that are sized to interstitially penetrate the substrate to optimize inoculation of an agricultural substrate.
  • Spherical conglomerations are sized smaller than 2 millimeters in diameter, preferably between 10 microns to 1 millimeter in diameter.
  • addition of a small molecule compound enables passive absorption of aqueous extract through lining of oral cavity, oesophagus, stomach and upper portions of small intestine. Addition of small molecule compound further facilitates active absorption of unabsorbed components, if any, at distal end of the small intestine.
  • extracts prepared from myceliated agricultural substrates and associated with one or more small molecule compound(s), further comprise of honey.
  • honey or dry honey can form a novel, water-soluble delivery system for delivering pharmacologically active compounds, which are quickly metabolized.
  • dry honey as used herein means bee honey whose physical state is somewhat more solid than liquid at room temperature.
  • Mycelia extracts of the present invention have low glycemic index, which adds health-care benefits to the honey formulations. This low-glycemic effect can be enhanced by manipulating the honey formulations into pills, capsules and the like.
  • the pure culture of fungal strain can be selected from a group comprising Hericium erinaceus, Tremella fuciformis, Agaricus blazei, Cordyceps sinensis, Flammulina velutipes, Ganoderma lucidum, Grifola frondosa, Letinula edodes, Phellenis linteus, Polyporus umbellatus, Inonotus obliquus, Pleurotus ostreatus, P. eryngii, P. citrinopileatus, P. djamor, Trametes versicolor, Volvariella volvacea, Hypsizygus marmoreus, Pholiota nameko, Tuber melanosporum, Moschella hortensis , and combinations thereof.
  • agricultural substrate is selected from the group comprising one or more of grains, cereals, seeds, non-legume beans, tubers, citrus fruits, berries, dry fruits, spices, herbs, vegetables and combinations thereof.
  • Agricultural substrates of the present invention can be pre-processed before inoculation. Pre-processing depends on nature of the substrate, wherein the pre-processing can comprise heat treatment including pasteurization and heat sterilization and/or filtration, based on nature of the substrate in order to eradicate or minimize microbial load present on its surface.
  • pre-processing depends on nature of the substrate, wherein the pre-processing can comprise heat treatment including pasteurization and heat sterilization and/or filtration, based on nature of the substrate in order to eradicate or minimize microbial load present on its surface.
  • agricultural substrates such as grains, cereals, and seeds, prior to inoculation with pure culture of fungal species, are subjected to heat sterilization treatment comprising pressure cooking for 90 minutes at 15 lb/inch square in order to remove microbial content present on the substrate without adversely affecting its taste and nutritional quality.
  • agricultural substrates such as herbs, spices, dry fruits, vanilla beans, coffee beans can be pasteurized by placing in glass jars or plastic growth bags and subjected to dry heat treatment at 145 degrees F. to 195 degrees F. for 30 to 90 minutes in covered stainless steel trays.
  • substrates such as honey and aqueous solution of substrate are subjected to filtration in order to remove microbial content prior to inoculation with pure strains of fungal culture.
  • the substrate when an agricultural substrate has substrate elements defining interstitial spaces in between such as rice, the substrate can be pre-processed before inoculation by at least partially coating a surface of the substrate with at least one myceliation enhancing compound including but not limiting to vegetable oil such as olive oil. Vegetable oil can increase interstitial spaces between substrate elements to improve myceliation.
  • vegetable oil can be olive oil, which may have neuro-protectant properties.
  • the substrate can also be coated with at least one substance known to exhibit neuroregenerative and/or neuroprotective properties such as lecithin.
  • present invention provides a method of preparing a nutraceutical composition with neuroregenerative properties from an extract of myceliated agricultural substrates, wherein inoculation of the substrate is carried out using pure culture of Hericium erinaceus and Tremella fuciformis .
  • Neuroregenerative properties of Hericium erinaceus and Tremella fuciformis are known in the art.
  • mycelial structures of H. erinaceus show presence of bioactive compounds with improved neuroregenerative effects than the compounds present in the fruiting bodies of H. erinaceus.
  • present invention provides an extract of myceliated agricultural substrate with neuroprotective activities, wherein the substrate is at least partially coated with vegetable oil, lecithin or combinations thereof.
  • vegetable oil is olive oil. Pre-processing of the agricultural substrate with lecithin enhances neuroprotective properties of the extract.
  • surface of the substrate can be coated with a mixture of vegetable oil and lecithin before the substrate is inoculated with a pure strain of fungal strain comprising Hericium erinaceus and Tremella fuciformis followed by myceliation and subsequent extraction steps as described herein to produce nutraceutical compositions with enhanced neuroregenerative and/or neuroprotective properties.
  • extract of the present invention can be prepared from a water substrate mixture, wherein the water substrate mixture is obtained by boiling the myceliated substrate in water at a suitable temperature range for a suitable duration of time.
  • extract of the present invention can be prepared by mixing myceliated substrate with specific amount of solvents such as ethyl alcohol, ethyl acetate, diethyl ether and incubated for a particular period of time in order to form solvent based extract.
  • solvents such as ethyl alcohol, ethyl acetate, diethyl ether
  • the solvent based extract can be subjected to freeze drying in order to remove aqueous solvent and organic solvent from the extract.
  • aqueous extract of the present invention can be separated from water substrate mixture using separation methods such as filtration, siphoning, centrifugation, vortex sedimentation, and agitation, heating among such separation methods.
  • Agricultural substrates that are myceliated in accordance with this invention can include one or more of cereals, grains, species of wheat, rye, brown rice, white rice, red rice, gold rice, wild rice, rice, barley, triticale, rice, sorghum, oats, millets, quinoa, buckwheat, fonio, amaranth, teff and durum; apples and pears, apricots, cherries, almonds, peaches, strawberries, raisins, manioc, cocoa, banana, Rubiaceae sp.
  • Lemon Ironbark Eucalyptus staigeriana
  • Lemon mint Lemon Myrtle ( Backhousia citriodora ), Lemon Thyme
  • Lemon verbena Lippia citriodora
  • Licorice-adaptogen Lime Flower, Limnophila aromatica, Lingzhi, Linseed, Liquorice, Long pepper, Lovage ( Levisticum officinale ), Luohanguo, Mace, Mahlab, Malabathrum, Manchurian Thorn Tree ( Aralia manchurica ), Mandrake, Marjoram ( Origanum majorana ), Marrubium vulgare, Marsh Labrador Tea, Marshmallow, Mastic, Meadowsweet, Mei Yen, Melegueta pepper ( Aframomum melegueta ), Mint, Milk thistle ( Silybum ), Bergamot ( Monarda didyma ), Motherwort, Mountain Skullcap, Mullein ( Verbascum
  • Heracleoticum Orris root, Osmorhiza, Olive Leaf (used in tea and as herbal supplement), Panax quinquefolius , Pandan leaf, Paprika, Parsley ( Petroselinum crispum ), Passion Flower, Patchouli, Pennyroyal, Pepper (black, white, and green), Peppermint, Peppermint Gum ( Eucalyptus dives ), Perilla, Plantain, Pomegranate, Ponch phoran, Poppy seed, Primrose (Primula), candied flowers, dry tea mixes, Psyllium, Purslane, Quassia, Quatre epices, Ramsons, Raspberry (leaves), Reishi, Restharrow, Rhodiola rosea, Riberry ( Syzygium luehmannii ), Rocket/Arugula, Roman chamomile, Rooibos, Rosehips, Rosemary ( Rosmarinus officinalis ), Rowan Berries, Rue, Safflower, Saffron, Sage
  • myceliation of green coffee bean can result in a decrease of compounds that is responsible for bitter taste of coffee and caffeine content, thus coffee brewed from roasted, myceliated coffee beans can eventually offers a smooth drink of coffee with low caffeine content.
  • extract obtained from agricultural substrates myceliated by inoculating with pure culture of Ganoderma lucidum, Pleurotus spp., Cordyceps sinensis can show enhanced color, texture, flavor and smell.
  • extract obtained from myceliated substrates inoculated with pure cultures of fungal strains can be selected from one or more of A. blazei, C. sinensis, G. lucidum, H. erinaceus, G. frondosa, P. eryngii, P. ostreatus, P. citrinopileatus, P. djamor, T versicolor, L. edodes, F. velutipes, V. volvacea, H. marmoreus, P. nameko, T melanosporum, M hortensis, P. umbellatus , and T. fuciformis , and can contain high level of nucleic acids including RNA.
  • the level of RNA content can be greatly reduced by subjecting myceliated substrate to heat treatment at a specific temperature for a predetermined period of time followed by cooling at room temperature.
  • extract can be formulated into a nutraceutical composition comprising of a capsule, pill, tablet, syrup, drink mix, fluid, lozenge, powder and combinations thereof, by following the techniques known in the art.
  • nutraceutical composition can further comprise at least one pharmaceutically acceptable excipient selected from the group comprising binder, coating substance, disintegrant, filler, flavor, color, lubricant, glidant, sorbent, preservative and sweetener.
  • nutraceutical composition can further comprise a dietary supplement selected from the group comprising proteins, vitamins, minerals, amino acids, dietary fiber, microelements and combinations thereof.
  • extract and nutraceutical composition can be produced using solid state or liquid state fermentation using small batch mode or continuous mode of fermentation methods by employing small scale container to large scale, commercial fermenting vessel.
  • extract comprises of bioactive compounds such as polysaccharides, glucan, sterols, fatty acids, phenol, triterpenes, proteins, amino acids, glycoproteins, vitamins, mineral salts and its combinations thereof.
  • bioactive compounds such as polysaccharides, glucan, sterols, fatty acids, phenol, triterpenes, proteins, amino acids, glycoproteins, vitamins, mineral salts and its combinations thereof.
  • extract comprises of health benefit properties such as anti-aging, anti-tumor, anti-bacterial, anti-fungal, anti-viral activity, cholesterol regulation, neuroprotection, anti-oxidant, immunomodulation and hepatoprotective properties.
  • health benefit properties such as anti-aging, anti-tumor, anti-bacterial, anti-fungal, anti-viral activity, cholesterol regulation, neuroprotection, anti-oxidant, immunomodulation and hepatoprotective properties.
  • 100 gram to 1000 grams of myceliated agricultural substrate is extracted using 4 liters to 10 liters of boiling water and added with 1 gram to 100 grams of citric acid and ascorbic acid and left for 1 to 4 hours.
  • the extract is filtered through a stainless steel colander for separating a liquid extract, which is further concentrated into 1 ⁇ 2 to 1 ⁇ 8 of the original volume by boiling and stirring.
  • 1 ml to 20 ml citrus essential oil and 100 grams to 200 grams dry honey are added with vigorous stirring at 145 degree F. to 165 degree F. for 10 min to 45 min, then cooled down to 100 degree F. to 125 degree F.
  • Honey formulations prepared from myceliated substrate in accordance with the present invention are stirred for 10 min to 90 min at 100 degree F. to 125 degree F. and bottled for further use or sale or storage.
  • Raw flax seed and chia seed myceliated with Tremella fuciformus, Pholiota nameko, Flammulina velutipes , and Ganoderma lucidum produces extraordinarily slippery jelly like product which is filtered, purified and formulated as a nutraceutical composition with clinical application including health beneficial properties such as digestive enhancement and as a lubricant for mucus membranes.
  • Extracts of fungi used herein are known to be of low glycemic index which adds health-care benefits to the honey formulations. This low-glyemic effect is enhanced by manipulating the honey formulations into pills and or capsules, which take longer to metabolize than the honey formulations by themselves.
  • Honey formulations are diluted at 100 degrees F. to 145 degrees F. with 1 part honey formulations mixed with 2 to 10 parts purified cellulose powder and/or 2 to 10 parts raw mushroom powder (w/w), as filler, followed by mixing and pressing the mix into molds at 20 lb/in 2 to 200 lb/in 2 pressure at 70 degrees F. to 100 degrees F. in order to make pills or capsules, which are then consumed in order to enjoy the related health-care benefits of this invention.
  • suppositories which also take longer to metabolize than honey formulations themselves, are made as follows: Mixing 1 to 10 parts of honey with 10 to 1000 parts of coconut butter modified with 1 to 10 parts olive oil followed by heating the mixture at 145 degrees F. to 175 degrees F. After vigorous mixing, formulation is brought back to room temperature to cool, and formulated into 1 inch to 2 inch long cylinders of 1 ⁇ 2 in diameter and packed as nutraceutical tablets.

Abstract

The present invention provides an aqueous extract of a myceliated agricultural substrate for use as a nutraceutical or food composition for human consumption comprising at least one small molecule compound, wherein mycelia is grown on an agricultural substrate by inoculating the agricultural substrate with a pure strain of a fungal culture selected from the group comprising Basidiomycota and Ascomycota derived from a liquid fermentation, under optimum growth conditions. The present invention further provides methods of formation of an aqueous extract and nutraceutical or food compositions obtained from the extract. The aqueous extract and the nutraceutical compositions obtained from the extract thereof have neuroprotective and neuroregenerative properties amongst many other therapeutic properties.

Description

    RELATED APPLICATIONS
  • This patent application claims the benefit of U.S. Provisional Patent Application No. 61/697,506, filed 6 Sep. 2012, and U.S. Provisional Patent Application No. 61/802,256, filed 15 Mar. 2013. This patent application also relates in subject matter to commonly assigned U.S. patent application Ser. No. 13/859,719, filed 9 Apr. 2013. The disclosures of each of these related patent applications are incorporated herein by reference.
  • FIELD OF THE INVENTION
  • The present invention pertains to an extract of a myceliated agricultural substrate and its use as nutraceutical, food compositions and products.
  • BACKGROUND OF THE INVENTION
  • Mycelium forms a vegetative part of a fungus consisting of a network of branched, tubular filaments referred to as hyphal structures. The mycelial structures play a pivotal role in nutrient absorption by releasing enzymes into the substrate, including enzymes for breaking down complex organic polymers into simpler compounds which are absorbed through hyphal walls.
  • Typically a fungal spore germinates into a monokaryotic mycelia and forms a dikaryotic mycelium on joining with other compatible mycelia and results in formation of fruiting bodies such as mushrooms. Mycelium has been used as a primary source for medicinal extracts and animal food, while the fruiting bodies or mushrooms are generally used as human food.
  • Spore-bearing mushrooms and vegetative mycelia of edible and medicinal fungal species produce pharmacologically active metabolites including polysaccharides, proteins, glycoproteins, enzymes, glucans (alpha, beta), triterpenes, phenols and sterols.
  • It is known from the prior art that mycelial structures and metabolites of beneficial fungal species possess enhanced biological activities and numerous therapeutic properties. Metabolites from more than 650 mushroom species are known to have anti-tumor and immunomodulatory effects on humans. For instance, Agaricus blazei is referenced to produce unique alpha and beta-linked glucans called glucomannan and riboglucan, which are known anti-viral compounds. A. blazei polysaccharide extracts have been shown to have anti-cancer activity.
  • Pharmaceutical substances with potent health enhancing properties were isolated recently from medicinal mushrooms and distributed worldwide. Many of them are pharmaceutical products, while others represent a novel class of dietary supplements or “mushroom nutraceuticals”. For instance, antitumor polysaccharides, such as hetero-β-glucans and their protein complexes (e.g., xyloglucans, and acidic (β-glucan containing uronic acid) as well as dietary fiber, lectins, and triterpenoids, have been isolated from medicinal mushrooms.
  • Nutraceutical compositions and food supplements with therapeutic activity produced from medicinal and edible mushrooms or fungi have been known in the art. For example, US Patent Publication US20050180989 discloses treatment of hyperlipemia by use of an antihyperlipidemic agent and food containing T. matsutake wherein T. matsutake is provided in the form of mycelia, broth or fruit bodies including spores; US Patent Publication US2006/0280753 discloses a composition and a method for obtaining a nutritional food product comprising a UV irradiated, fermented and dried mycelium/solid substrate mixture; US Patent Publication US2011/0091579 discloses production of vitamin D2 enriched mushrooms and fungi for treatment of oxidative stress, Alzheimer's disease; US Patent Publication US2011/0206721 discloses fermented soy nutritional supplements including mushroom components and WIPO publication WO2011/151831 discloses pharmaceutical compositions comprising extracts of Cyathus Striatus mushrooms.
  • Fungi are metabolically similar to animals but structurally similar to plants in that they possess a rigid cell wall formed largely of long sugar molecule chains joined by somewhat difficult to digest beta (b-) linkages and to a smaller extent more easily digestible alpha (a-) linkages in conjunction with membrane-bound proteins. In contrast, plant cell walls are made of cellulose polysaccharides whose 1->4 glycosidic Glucose linkages are likewise difficult to digest by our enzymes; however, as the cell walls of Fungi are primarily composed of 1->3 glycosidic linkages, with 1->6 linked side chains, they may be broken down by minimal processing using water, heat and mechanical treatment into smaller, more easily digestible, immunologically-active polysaccharide molecules of variable microparticulate size called b-glucans, and related glycoprotein compounds. The immune response to Glucan is dependent upon a- or b-glucan structure, which has primary, secondary, and chiral tertiary structures, explaining the differences in immune response to each Fungi's unique a- and or b-glucan profile.
  • Both mushrooms and mycelium produce polysaccharides and metabolites, ingestion of which induces positive immunomodulation in human body. However, most medicinal and/or gourmet mushrooms take a very long time to come to fruition.
  • Thus there is an unmet need in the art to exploit the use of mycelial tissues instead of fruiting bodies of a variety of medicinal and edible fungi species, for myceliation and subsequent extraction to quickly produce extracts of myceliated substrates where such extracts should be used in formulating nutraceutical compositions that provide unique properties similar to mushrooms and or mycelium, including delicious and nutritious meat substitutes. These types of nutraceuticals should attract consumers who wish to derive the general immunomodulating, anti-aging, aphrodisiac, anti-tumour, anti-viral, anti-bacterial, and/or anti-fungal properties, activities, and benefits, by orally consuming substrates which has been converted to edible presentations of a- and b-glucans, glycoproteins, proteins, ergosterols, sterols, triterpenes, and fatty acids in the form of nutraceuticals formulations. Furthermore, such new and better method of preparing an extract of myceliated agricultural material should be suitable for a variety of mycelial agricultural substrates in order to produce nutraceutical compositions with enhanced health benefits.
  • Thus the present invention satisfies these unmet needs and generally overcomes the deficiencies prevalent in the art, by developing an extract of a myceliated agricultural substrate for use in formulating nutraceutical compositions, wherein the compositions offer a variety of health benefits including neuroregeneration and neuroprotection properties.
  • SUMMARY OF THE INVENTION
  • The present invention relates to an aqueous extract of a myceliated agricultural substrate for use as a nutraceutical or food composition for human consumption comprising at least one small molecule compound, wherein mycelia is grown on an agricultural substrate by inoculating the agricultural substrate with a pure strain of a fungal culture selected from a group comprising Basidiomycota and Ascomycota derived from a liquid fermentation, under optimum growth conditions, wherein the at least one small molecule compound enhances bioavailability, water solubility and passive absorption of the aqueous extract.
  • In one embodiment of the present invention, a small molecule compound can be selected from the group comprising citric acid, ascorbic acid, honey, cane sugar, grape fruit essential oil, citrus essential oil, ethyl alcohol and combinations thereof.
  • In one embodiment, extract of a myceliated agricultural substrate of the present invention has neuroprotective and neuroregenerative properties, wherein fungi strains are selected from the group comprising Tremella fuciformis and Hericium erinaceus, further wherein the substrate is pre-processed before myceliation by at least partially coating the substrate with lecithin, vegetable oil or combinations thereof.
  • The present invention further provides a method of preparation of an aqueous extract of a myceliated agricultural substrate for use as a nutraceutical composition for human consumption, comprising the steps of
      • inoculating an agricultural substrate with a pure strain of a fungal culture selected from the group comprising Basidiomycota and Ascomycota, derived from a liquid fermentation under optimum growth conditions;
      • enabling mycelial growth on the agricultural substrate till the mycelial growth reaches a desired stage to obtain a myceliated agricultural substrate;
      • obtaining a water-substrate mixture by boiling the myceliated agricultural substrate in water for a suitable duration of time and at suitable temperature;
      • separating aqueous and non-aqueous components from the water-substrate mixture;
      • adding at least one small molecule compound to the aqueous component to form the aqueous extract;
      • wherein the at least one small molecule compound enhances bioavailability, water solubility and passive absorption of the aqueous extract.
  • The present invention further provides a method for producing a nutraceutical composition with neuroprotective and neuroregenerative properties from an extract of a myceliated agricultural substrate comprising the steps of:
      • optionally pre-processing an agricultural substrate depending on nature of the substrate;
      • inoculating the agricultural substrate with a pure strain of a fungal culture selected from the group comprising Tremella fuciformis and Hericium erinaceus, derived from a liquid fermentation under optimum growth conditions;
      • enabling mycelial growth on the agricultural substrate till the mycelial growth reaches a desired stage to obtain a myceliated agricultural substrate;
      • obtaining a water-substrate mixture by boiling the myceliated agricultural substrate in water for a suitable duration of time and at a suitable temperature;
      • separating aqueous and non-aqueous components from the water-substrate mixture;
      • adding at least one small molecule compound to the aqueous component to form the aqueous extract; and
      • optionally formulating the aqueous extract into nutraceutical or food composition using techniques known in the art;
  • wherein the at least one small molecule compound enhances bioavailability, water solubility and passive absorption of the aqueous extract.
  • In one embodiment, the pre-processing step includes, but not limited to, for example at least partially coating a surface of the substrate with lecithin, vegetable oil or combinations thereof. Preferably the vegetable oil is olive oil.
  • In an embodiment, the mycelia from strains of Basidiomycota and Ascomycota are grown in liquid-state culture and used to ferment solid-state agricultural substrates.
  • Nutraceutical or food composition of the present invention can further be in a form such as capsule, pill, tablet, syrup, drink mix, fluid, lozenge, powder and combinations thereof.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is a flowchart of a method for preparing an extract of myceliated agricultural substrates.
  • FIG. 2 is a flowchart of a method of preparation of a nutraceutical or food composition from an extract of myceliated agricultural substrates.
  • DETAILED DESCRIPTION OF THE INVENTION
  • The present invention provides an aqueous extract from a myceliated agricultural substrate for use in formulating nutraceutical and food compositions, wherein the compositions offer a variety of health benefits including neuroregeneration and neuroprotection properties.
  • Mycelium extracts have been shown to contain a variety of pharmacologically important compounds. Utilization of conventional pharmacological techniques of crystallizing or otherwise solidifying compounds of interest for delivery in pill form may diminish or destroy the effectiveness of the compounds by altering the macromolecular structure, generally done by chemically modifying polysaccharide structure, for example by way of Smith degradation, formolysis, and carboxymethylation. Pharmacological activity of these compounds depends on their molecular structure in solution.
  • The present invention provides mycelia extracts to the human body fit for oral ingestion in a water-soluble, unaltered form, by remaining in solution in association with small molecule compounds.
  • FIG. 1 shows a flow chart of a method of preparation of an extract from myceliated agricultural substrates wherein,
      • step 10 provides an agricultural substrate;
      • step 12 optionally pre-processes the substrate based on nature of the substrate,
      • step 14 inoculates an agricultural substrate with pure culture of fungal strains selected from Basidiomycota and Ascomycota;
      • step 16 enables mycelium growth on the substrate under optimum growth conditions to obtain a myceliated agricultural substrate;
      • step 18 grows the mycelium on the myceliated agricultural substrate till the mycelial growth reaches a desired stage;
      • step 20 obtains a water substrate mixture by boiling the myceliated agricultural substrate with water;
      • step 22 separates aqueous and non-aqueous components from the water substrate mixture; and
      • step 24 adds at least one small molecule component to the aqueous component to form the aqueous extract of the myceliated substrate.
  • The present invention further provides a method of preparing a nutraceutical composition from an extract of myceliated agricultural substrates as shown in FIG. 2, wherein,
      • step 30 provides an agricultural substrate,
      • step 32 optionally pre-processes the substrate based on nature of the substrate,
      • step 34 inoculates the substrate with pure culture of fungal strains selected from Tremella fuciformis and Hericium erinaceus,
      • step 36 enables mycelium growth on the substrate under optimum growth conditions till a desired stage is reached to obtain a myceliated substrate;
      • step 38 obtains a water substrate mixture by boiling the myceliated substrate with water;
      • step 40 separates aqueous and non-aqueous components from the water substrate mixture;
      • step 42 adding at least one small molecule compound to the aqueous extract; and
      • step 44 optionally formulates the aqueous extract into a nutraceutical or food composition using techniques known in the art.
  • In an embodiment, optimum growth conditions for mycelial growth can be controlled by controlling parameters such as selective pH, temperature, humidity, incubation period, media composition, aeration and pressure among such other parameters.
  • Enabling of mycelia growth on a substrate can further comprise of maintaining liquid media under stationary condition or mixing the liquid media by utilizing mixing methods such as agitation, stirring, swirling continuously or intermittently among such other mixing methods.
  • In an embodiment, the desired stage of mycelia growth can be reached, for example, when fruiting bodies begin to appear on a surface of an agricultural substrate.
  • In one embodiment, the pre-processing step is selected from the group comprising:
  • a. heat treatment including pasteurization or heat sterilization,
    b. filtration,
    c. at least partial coating of a surface of the substrate with at least one myceliation enhancing compound selected from a vegetable oil such as olive oil,
    d. at least partial coating of a surface of the substrate with at least one substance known to exhibit neuroregenerative and neuroprotective properties such as lecithin.
  • In one embodiment, aqueous component, obtained after boiling a myceliated substrate with water, contains polysaccharides and other beneficial components suspended in water. The non-aqueous component contains substrate solids. Separation of aqueous and non-aqueous components can be accomplished by methods such as filtering or siphoning or other methods known in the art.
  • In an embodiment of the present invention, the small molecule compound is selected from the group comprising citric acid, ascorbic acid, honey, cane sugar, grape fruit essential oil, citrus essential oil, ethyl alcohol and combinations thereof, wherein an addition of the small molecule compound facilitates water solubility, bioavailability and passive absorption of the aqueous extract.
  • In an embodiment, the agricultural substrate is inoculated by liquid media comprising an aliquot of pure culture of a fungal strain selected from Basidiomycota and Ascomycota, wherein the fungal strains are derived from a liquid state fermentation.
  • In a further embodiment, the liquid media can be kept either stationary or non-stationary during liquid state fermentation. The liquid media can be stationary creating a semi-anaerobic environment that enhances a direct mycelial growth downward from a floating mass into the liquid media. In another embodiment, the liquid media is mixed by methods such as agitation, swirling and stirring.
  • In one embodiment, mycelia from strains, selected from Basidiomycota and Ascomycota Fungi, is grown in liquid-state culture and used to ferment solid-state agricultural substrates.
  • In a yet another embodiment, liquid media can be injected with sterile air to deliver oxygen to the liquid media.
  • In a further embodiment, liquid state fermentation yields spherical conglomerations of culture that are sized to interstitially penetrate the substrate to optimize inoculation of an agricultural substrate. Spherical conglomerations are sized smaller than 2 millimeters in diameter, preferably between 10 microns to 1 millimeter in diameter.
  • In another embodiment of the present invention, addition of a small molecule compound enables passive absorption of aqueous extract through lining of oral cavity, oesophagus, stomach and upper portions of small intestine. Addition of small molecule compound further facilitates active absorption of unabsorbed components, if any, at distal end of the small intestine.
  • In another embodiment of the present invention, extracts prepared from myceliated agricultural substrates and associated with one or more small molecule compound(s), further comprise of honey. These extracts with honey or dry honey can form a novel, water-soluble delivery system for delivering pharmacologically active compounds, which are quickly metabolized. The term “dry honey” as used herein means bee honey whose physical state is somewhat more solid than liquid at room temperature. Mycelia extracts of the present invention have low glycemic index, which adds health-care benefits to the honey formulations. This low-glycemic effect can be enhanced by manipulating the honey formulations into pills, capsules and the like.
  • Specific Fungi strain selection and growing of strains organically is important for maximizing production of immunologically active-polysaccharides and metabolites from agricultural substrate(s). In an embodiment, the pure culture of fungal strain can be selected from a group comprising Hericium erinaceus, Tremella fuciformis, Agaricus blazei, Cordyceps sinensis, Flammulina velutipes, Ganoderma lucidum, Grifola frondosa, Letinula edodes, Phellenis linteus, Polyporus umbellatus, Inonotus obliquus, Pleurotus ostreatus, P. eryngii, P. citrinopileatus, P. djamor, Trametes versicolor, Volvariella volvacea, Hypsizygus marmoreus, Pholiota nameko, Tuber melanosporum, Moschella hortensis, and combinations thereof.
  • In an embodiment, agricultural substrate is selected from the group comprising one or more of grains, cereals, seeds, non-legume beans, tubers, citrus fruits, berries, dry fruits, spices, herbs, vegetables and combinations thereof.
  • Agricultural substrates of the present invention can be pre-processed before inoculation. Pre-processing depends on nature of the substrate, wherein the pre-processing can comprise heat treatment including pasteurization and heat sterilization and/or filtration, based on nature of the substrate in order to eradicate or minimize microbial load present on its surface.
  • In one exemplary embodiment, agricultural substrates such as grains, cereals, and seeds, prior to inoculation with pure culture of fungal species, are subjected to heat sterilization treatment comprising pressure cooking for 90 minutes at 15 lb/inch square in order to remove microbial content present on the substrate without adversely affecting its taste and nutritional quality.
  • In another exemplary embodiment, agricultural substrates such as herbs, spices, dry fruits, vanilla beans, coffee beans can be pasteurized by placing in glass jars or plastic growth bags and subjected to dry heat treatment at 145 degrees F. to 195 degrees F. for 30 to 90 minutes in covered stainless steel trays.
  • In a further exemplary embodiment, substrates such as honey and aqueous solution of substrate are subjected to filtration in order to remove microbial content prior to inoculation with pure strains of fungal culture.
  • In accordance with the present invention, when an agricultural substrate has substrate elements defining interstitial spaces in between such as rice, the substrate can be pre-processed before inoculation by at least partially coating a surface of the substrate with at least one myceliation enhancing compound including but not limiting to vegetable oil such as olive oil. Vegetable oil can increase interstitial spaces between substrate elements to improve myceliation. Preferably, vegetable oil can be olive oil, which may have neuro-protectant properties. Further, the substrate can also be coated with at least one substance known to exhibit neuroregenerative and/or neuroprotective properties such as lecithin.
  • In an embodiment, present invention provides a method of preparing a nutraceutical composition with neuroregenerative properties from an extract of myceliated agricultural substrates, wherein inoculation of the substrate is carried out using pure culture of Hericium erinaceus and Tremella fuciformis. Neuroregenerative properties of Hericium erinaceus and Tremella fuciformis are known in the art. Moreover, it is also known in the art that mycelial structures of H. erinaceus show presence of bioactive compounds with improved neuroregenerative effects than the compounds present in the fruiting bodies of H. erinaceus.
  • In another embodiment, present invention provides an extract of myceliated agricultural substrate with neuroprotective activities, wherein the substrate is at least partially coated with vegetable oil, lecithin or combinations thereof. In one preferred embodiment, vegetable oil is olive oil. Pre-processing of the agricultural substrate with lecithin enhances neuroprotective properties of the extract.
  • In one embodiment, surface of the substrate can be coated with a mixture of vegetable oil and lecithin before the substrate is inoculated with a pure strain of fungal strain comprising Hericium erinaceus and Tremella fuciformis followed by myceliation and subsequent extraction steps as described herein to produce nutraceutical compositions with enhanced neuroregenerative and/or neuroprotective properties.
  • In an embodiment, extract of the present invention can be prepared from a water substrate mixture, wherein the water substrate mixture is obtained by boiling the myceliated substrate in water at a suitable temperature range for a suitable duration of time.
  • In an alternate embodiment, extract of the present invention can be prepared by mixing myceliated substrate with specific amount of solvents such as ethyl alcohol, ethyl acetate, diethyl ether and incubated for a particular period of time in order to form solvent based extract. In a further embodiment, the solvent based extract can be subjected to freeze drying in order to remove aqueous solvent and organic solvent from the extract.
  • In an embodiment, aqueous extract of the present invention can be separated from water substrate mixture using separation methods such as filtration, siphoning, centrifugation, vortex sedimentation, and agitation, heating among such separation methods.
  • Agricultural substrates that are myceliated in accordance with this invention can include one or more of cereals, grains, species of wheat, rye, brown rice, white rice, red rice, gold rice, wild rice, rice, barley, triticale, rice, sorghum, oats, millets, quinoa, buckwheat, fonio, amaranth, teff and durum; apples and pears, apricots, cherries, almonds, peaches, strawberries, raisins, manioc, cocoa, banana, Rubiaceae sp. (coffee), lemons, oranges and grapefruit; tomatoes, potatoes, peppers, eggplant, Allspice, mango powder, Angelica, Anise (Pimpinella anisum), Aniseed myrtle (Syzygium anisatum), Annatto (Bixa orellana), Apple mint (Mentha suaveolens), Artemisia vulgaris, Mugwort, Asafoetida (Ferula assafoetida), Berberis, Banana, Basil (Ocimum basilicum), Bay leaves, Bistort (Persicaria bistorta), Black cardamom, Black cumin, Blackcurrant, Black limes, Bladder wrack (Fucus vesiculosus), Blue Cohosh, Blue-leaved Mallee (Eucalyptus polybractea), Bog Labrador Tea (Rhododendron groenlandicum), Boldo (Peumus boldus), Bolivian Coriander (Porophyllum ruderale), Borage (Borago officinalis), Calamus, Calendula, Calumba (Jateorhiza calumba), Chamomile, Cannabis, Caper (Capparis spinosa), Caraway, Cardamom, Carob Pod, Cassia, Casuarina, Catnip, Cat's Claw, Catsear, Cayenne pepper, Celastrus Paniculatus, Comfrey, Celery salt, Celery seed, Centaury, Chervil (Anthriscus cerefolium), Chickweed, Chicory, Chile pepper, Chili powder, Cinchona, Chives (Allium schoenoprasum), Cicely (Myrrhis odorata), Cilantro (see Coriander) (Coriandrum sativum), Cinnamon (and Cassia), Cinnamon Myrtle (Backhousia myrtifolia), Clary, Cleavers, Clover, Cloves, Coltsfoot, Comfrey, Common Rue, Condurango, Coptis, Coriander, Costmary (Tanacetum balsamita), Couchgrass, Cow Parsley (Anthriscus sylvestris), Cowslip, Cramp Bark (Viburnum opulus), Cress, Cuban Oregano (Plectranthus amboinicus), Cudweed, Cumin, Curry leaf (Murraya koenigii), Damiana (Turnera aphrodisiaca), Dandelion (Taraxacum officinale), Demulcent, Devil's claw (Harpagophytum procumbens), Dill seed, Dill (Anethum graveolens), Dorrigo Pepper (Tasmannia stipitata), Echinacea, Echinopanax Elatum, Edelweiss, Elderberry, Elderflower, Elecampane, Eleutherococcus senticosus, Epazote (Chenopodium ambrosioides), Ephedra, Eryngium foetidum, Eucalyptus, Fennel (Foeniculum vulgare), Fenugreek, Feverfew, Figwort, Five-spice powder (Chinese), Fo-ti-tieng, Fumitory, Galangal, Garam masala, Garden cress, Garlic chives, Garlic, Ginger (Zingiber officinale), Ginkgo biloba, Ginseng, Ginseng, Siberian (Eleutherococcus senticosus), Goat's Rue (Galega officinalis), Goada masala, Golden Rod, Golden Seal, Gotu Kola, Grains of paradise (Aframomum melegueta), Grains of Selim (Xylopia aethiopica), Grape seed extract, Green tea, Ground Ivy, Guaco, Gypsywort, Hawthorn (Crataegus sanguines), Hawthorne Tree, Hemp, Herbes de Provence, Hibiscus, Holly, Holy Thistle, Hops, Horehound, Horseradish, Horsetail (Equisetum telmateia), Hyssop (Hyssopus officinalis), Jalap, Jasmine, Jiaogulan (Gynostemma pentaphyllum), Joe Pye weed (Gravelroot), John the Conqueror, Juniper, Kaffir Lime Leaves (Citrus hystrix, C. papedia), Kaala masala, Knotweed, Kokam, Labrador tea, Lady's Bedstraw, Lady's Mantle, Land cress, Lavender (Lavandula spp.), Ledum, Lemon Balm (Melissa Officinalis), Lemon basil, Lemongrass (Cymbopogon citratus, C. flexuosus, and other species), Lemon Ironbark (Eucalyptus staigeriana), Lemon mint, Lemon Myrtle (Backhousia citriodora), Lemon Thyme, Lemon verbena (Lippia citriodora), Licorice-adaptogen, Lime Flower, Limnophila aromatica, Lingzhi, Linseed, Liquorice, Long pepper, Lovage (Levisticum officinale), Luohanguo, Mace, Mahlab, Malabathrum, Manchurian Thorn Tree (Aralia manchurica), Mandrake, Marjoram (Origanum majorana), Marrubium vulgare, Marsh Labrador Tea, Marshmallow, Mastic, Meadowsweet, Mei Yen, Melegueta pepper (Aframomum melegueta), Mint, Milk thistle (Silybum), Bergamot (Monarda didyma), Motherwort, Mountain Skullcap, Mullein (Verbascum thapsus), Mustard, Mustard seed, Nashia inaguensis, Neem, Nepeta, Nettle, Nigella sativa, Kolanji, Black caraway, Noni, Nutmeg, Mace, Marijuana, Oenothera (Oenothera biennis), Olida (Eucalyptus olida), Oregano (Origanum vulgare, O. heracleoticum), Orris root, Osmorhiza, Olive Leaf (used in tea and as herbal supplement), Panax quinquefolius, Pandan leaf, Paprika, Parsley (Petroselinum crispum), Passion Flower, Patchouli, Pennyroyal, Pepper (black, white, and green), Peppermint, Peppermint Gum (Eucalyptus dives), Perilla, Plantain, Pomegranate, Ponch phoran, Poppy seed, Primrose (Primula), candied flowers, dry tea mixes, Psyllium, Purslane, Quassia, Quatre epices, Ramsons, Raspberry (leaves), Reishi, Restharrow, Rhodiola rosea, Riberry (Syzygium luehmannii), Rocket/Arugula, Roman chamomile, Rooibos, Rosehips, Rosemary (Rosmarinus officinalis), Rowan Berries, Rue, Safflower, Saffron, Sage (Salvia officinalis), Saigon Cinnamon, St John's Wort, Salad Burnet (Sanguisorba minor or Poterium sanguisorba), Salvia, Sichuan Pepper (Sansho), Sassafras, Savory (Satureja hortensis, S. Montana), Schisandra (Schisandra chinensis), Scutellaria costaricana, Senna (herb), Senna obtusifolia, Sesame seed, Sheep Sorrel, Shepherd's Purse, Sialagogue, Siberian Chaga, Siberian ginseng (Eleutherococcus senticosus), Siraitia grosvenorii (luohanguo), Skullcap, Sloe Berries, Smudge Stick, Sonchus, Sorrel (Rumex spp.), Southernwood, Spearmint, Speedwell, Squill, Star anise, Stevia, Strawberry Leaves, Suma (Pfaffia paniculata), Sumac, Summer savory, Sutherlandia frutescens, Sweet grass, Sweet cicely (Myrrhis odorata), Sweet woodruff, Szechuan pepper (Xanthoxylum piperitum), Tacamahac, Tamarind, Tandoori masala, Tansy, Tarragon (Artemisia dracunculus), Tea, Teucrium polium, That basil, Thistle, Thyme, Toor Dall, Tormentil, Tribulus terrestris, Tulsi (Ocimum tenuiflorum), Turmeric (Curcuma longa), Uva Ursi also known as Bearberry, Vanilla (Vanilla planifolia), Vasaka, Vervain, Vetiver, Vietnamese Coriander (Persicaria odorata), Wasabi (Wasabia japonica), Watercress, Wattleseed, Wild ginger, Wild Lettuce, Wild thyme, Winter savory, Witch Hazel, Wolfberry, Wood Avens, Wood Betony, Woodruff, Wormwood, Yarrow, Yerba Buena, Yohimbe, Za'atar, Zedoary Root, or derivations thereof in aqueous or semi-aqueous solution.
  • In an embodiment, myceliation of green coffee bean can result in a decrease of compounds that is responsible for bitter taste of coffee and caffeine content, thus coffee brewed from roasted, myceliated coffee beans can eventually offers a smooth drink of coffee with low caffeine content.
  • In an embodiment, extract obtained from agricultural substrates myceliated by inoculating with pure culture of Ganoderma lucidum, Pleurotus spp., Cordyceps sinensis can show enhanced color, texture, flavor and smell.
  • In an embodiment, extract obtained from myceliated substrates inoculated with pure cultures of fungal strains can be selected from one or more of A. blazei, C. sinensis, G. lucidum, H. erinaceus, G. frondosa, P. eryngii, P. ostreatus, P. citrinopileatus, P. djamor, T versicolor, L. edodes, F. velutipes, V. volvacea, H. marmoreus, P. nameko, T melanosporum, M hortensis, P. umbellatus, and T. fuciformis, and can contain high level of nucleic acids including RNA. The level of RNA content can be greatly reduced by subjecting myceliated substrate to heat treatment at a specific temperature for a predetermined period of time followed by cooling at room temperature.
  • In an embodiment, extract can be formulated into a nutraceutical composition comprising of a capsule, pill, tablet, syrup, drink mix, fluid, lozenge, powder and combinations thereof, by following the techniques known in the art.
  • In another embodiment, nutraceutical composition can further comprise at least one pharmaceutically acceptable excipient selected from the group comprising binder, coating substance, disintegrant, filler, flavor, color, lubricant, glidant, sorbent, preservative and sweetener.
  • In another embodiment, nutraceutical composition can further comprise a dietary supplement selected from the group comprising proteins, vitamins, minerals, amino acids, dietary fiber, microelements and combinations thereof.
  • In an embodiment, extract and nutraceutical composition can be produced using solid state or liquid state fermentation using small batch mode or continuous mode of fermentation methods by employing small scale container to large scale, commercial fermenting vessel.
  • In an embodiment, extract comprises of bioactive compounds such as polysaccharides, glucan, sterols, fatty acids, phenol, triterpenes, proteins, amino acids, glycoproteins, vitamins, mineral salts and its combinations thereof.
  • In an embodiment, extract comprises of health benefit properties such as anti-aging, anti-tumor, anti-bacterial, anti-fungal, anti-viral activity, cholesterol regulation, neuroprotection, anti-oxidant, immunomodulation and hepatoprotective properties.
  • While the preferred embodiments of the invention have been described above, it will be recognized and understood that various modifications may be made therein, and the appended claims are intended to cover all such modifications which may fall within the spirit and scope of the invention.
  • In the following, the present invention is described in more detail by way of examples. However, these examples are not intended to limit the scope of protection of the present invention in any way.
  • EXAMPLES Example 1 Decreasing Ribonucleic Acid Levels in Myceliated Substrate
  • Agricultural substrates completely myceliated by inoculating with pure cultures of fungal strains selected from A. blazei, C. sinensis, G. lucidum, H. erinaceus, G. frondosa, P. eryngii, P. ostreatus, P. citrinopileatus, P. djamor, T. versicolor, L. edodes, F. velutipes, V. volvacea, H. marmoreus, P. nameko, T. melanosporum, M. hortensis, P. umbellatus, and T. fuciformis are subjected to heat treatment prior to harvest for 1 min to 2 hours at 145 degree F. to 195 degree F. followed by recovery at room temperature for 45 min to 48 hours shows remarkable decrease in RNA levels and are formulated into different nutraceutical compositions.
  • Example 2 Extraction
  • 100 gram to 1000 grams of myceliated agricultural substrate is extracted using 4 liters to 10 liters of boiling water and added with 1 gram to 100 grams of citric acid and ascorbic acid and left for 1 to 4 hours. The extract is filtered through a stainless steel colander for separating a liquid extract, which is further concentrated into ½ to ⅛ of the original volume by boiling and stirring. To every 40 ml to 60 ml of hot liquid extract, 1 ml to 20 ml citrus essential oil and 100 grams to 200 grams dry honey are added with vigorous stirring at 145 degree F. to 165 degree F. for 10 min to 45 min, then cooled down to 100 degree F. to 125 degree F.
  • Honey formulations prepared from myceliated substrate in accordance with the present invention are stirred for 10 min to 90 min at 100 degree F. to 125 degree F. and bottled for further use or sale or storage.
  • Example 3 Nutraceutical Compositions
  • Raw flax seed and chia seed myceliated with Tremella fuciformus, Pholiota nameko, Flammulina velutipes, and Ganoderma lucidum, produces extraordinarily slippery jelly like product which is filtered, purified and formulated as a nutraceutical composition with clinical application including health beneficial properties such as digestive enhancement and as a lubricant for mucus membranes.
  • Extracts of fungi used herein are known to be of low glycemic index which adds health-care benefits to the honey formulations. This low-glyemic effect is enhanced by manipulating the honey formulations into pills and or capsules, which take longer to metabolize than the honey formulations by themselves. Honey formulations are diluted at 100 degrees F. to 145 degrees F. with 1 part honey formulations mixed with 2 to 10 parts purified cellulose powder and/or 2 to 10 parts raw mushroom powder (w/w), as filler, followed by mixing and pressing the mix into molds at 20 lb/in 2 to 200 lb/in 2 pressure at 70 degrees F. to 100 degrees F. in order to make pills or capsules, which are then consumed in order to enjoy the related health-care benefits of this invention.
  • Similarly, suppositories, which also take longer to metabolize than honey formulations themselves, are made as follows: Mixing 1 to 10 parts of honey with 10 to 1000 parts of coconut butter modified with 1 to 10 parts olive oil followed by heating the mixture at 145 degrees F. to 175 degrees F. After vigorous mixing, formulation is brought back to room temperature to cool, and formulated into 1 inch to 2 inch long cylinders of ½ in diameter and packed as nutraceutical tablets.

Claims (20)

What is claimed is:
1. An aqueous extract of a myceliated agricultural substrate for use as a nutraceutical or food composition for human consumption comprising at least one small molecule compound, wherein mycelia is grown on an agricultural substrate by inoculating said agricultural substrate with a pure strain of a fungal culture selected from the group comprising Basidiomycota and Ascomycota derived from a liquid state fermentation, under optimum growth conditions to obtain said myceliated agricultural substrate, wherein the at least one small molecule compound enhances bioavailability, water solubility and passive absorption of the aqueous extract.
2. The extract of claim 1, wherein the at least one small molecule compound is selected from the group comprising citric acid, ascorbic acid, honey, dry honey, cane sugar, grape fruit essential oil, citrus essential oil, tangerine, ethyl alcohol and combinations thereof.
3. The extract of claim 1, wherein the fungal culture is selected from the group comprising Hericium erinaceus, Tremella fuciformis, Agaricus blazei, Cordyceps sinensis, Flammulina velutipes, Ganoderma lucidum, Grifola frondosa, Letinula edodes, Phellenis linteus, Polyporus umbellatus, Inonotus obliquus, Pleurotus ostreatus, P. eryngii, P. citrinopileatus, P. djamor, Trametes versicolor, Volvariella volvacea, Hypsizygus marmoreus, Pholiota nameko, Tuber melanosporum, Moschella hortensis, and combinations thereof.
4. The extract of claim 1, wherein the agricultural substrate is selected from the group comprising grains, cereals, seeds, dry fruits, herbs, spices, citrus fruits, tubers, berries, vegetables, non-legume beans, and combinations thereof.
5. The extract of claim 1, wherein the agricultural substrate is at least partially coated with vegetable oil, lecithin, and combination thereof.
6. The extract of claim 1, wherein the extract comprises active metabolites selected from the group comprising polysaccharides, glycoproteins, enzymes, proteins, triterpenes, phenols, sterols, fatty acids, vitamins, mineral salts and combinations thereof.
7. The extract of claim 1, wherein the extract has therapeutic properties selected from the group comprising anti-aging, anti-tumor, anti-viral, anti-bacterial, anti-fungal, hepatoprotective, anti-oxidative, immunomodulating property, cholesterol regulating property and combinations thereof.
8. The extract of claim 1, wherein the liquid state fermentation yields spherical conglomerations of said fungal culture wherein said conglomerations are sized smaller than 2 millimeters in diameter.
9. The extract of claim 1, wherein said agricultural substrate is pre-processed before inoculation by treatments selected from the group comprising heat sterilization, pasteurization, filtration or combinations thereof.
10. A method of preparation of an aqueous extract of a myceliated agricultural substrate for use as a nutraceutical composition for human consumption, comprising the steps of:
inoculating an agricultural substrate with a pure strain of a fungal culture selected from the group comprising Basidiomycota and Ascomycota, derived from a liquid fermentation, under optimum growth conditions;
enabling mycelial growth on the agricultural substrate till the mycelial growth reaches a desired stage to obtain the myceliated agricultural substrate;
obtaining a water-substrate mixture by boiling the myceliated agricultural substrate in water for a suitable duration of time and at suitable temperature;
separating aqueous and non-aqueous components from the water-substrate mixture; and
adding at least one small molecule compound to the aqueous component to form an aqueous extract;
wherein the at least one small molecule compound enhances bioavailability, water solubility and passive absorption of the aqueous extract.
11. The method of claim 10, wherein said substrate is pre-processed by treatments selected from the group comprising heat sterilization, pasteurization, filtration and combinations thereof.
12. The method of claim 10, wherein the at least one small molecule compound is selected from the group comprising citric acid, ascorbic acid, honey, dry honey, cane sugar, grape fruit essential oil, citrus essential oil, ethyl alcohol, and combinations thereof.
13. The method of claim 10, wherein the agricultural substrate is selected from the group comprising one or more of grains, cereals, seeds, herbs, spices, dry fruits, berries, citrus fruits, tubers, vegetables, edible flowers, non-legume beans, and combinations thereof.
14. The method of claim 10, wherein the liquid media is kept either stationary or non-stationary during liquid state fermentation.
15. A method of preparation of an aqueous extract of a myceliated agricultural substrate for use as a nutraceutical composition for human consumption with neuroprotective and neuroregenerative activity, comprising the steps of:
optionally pre-processing an agricultural substrate based on nature of the agricultural substrate;
inoculating the agricultural substrate with a pure strain of a fungal culture selected from a group comprising Tremella fuciformis and Hericium erinaceus, derived from a liquid fermentation under optimum growth conditions;
enabling mycelial growth on the agricultural substrate till the mycelial growth reaches a predetermined stage to obtain the myceliated agricultural substrate;
obtaining a water-substrate mixture by boiling the myceliated agricultural substrate in water for a suitable duration of time and at suitable temperature;
separating aqueous and non-aqueous components from the water-substrate mixture;
adding at least one small molecule compound to the aqueous component to form the aqueous extract; and
optionally formulating the aqueous extract into a nutraceutical or food composition;
wherein the at least one small molecule compound enhances bioavailability, water solubility and passive absorption of the aqueous extract.
16. The method of claim 15, wherein the at least one small molecule compound is selected from the group comprising citric acid, ascorbic acid, honey, cane sugar, grape fruit essential oil, citrus essential oil, ethyl alcohol and combinations thereof.
17. The method of claim 15, wherein the pre-processing is selected from the group comprising:
a. heat treatment comprising pasteurization or heat sterilization;
b. filtration;
c. at least partial coating of a surface of the agricultural substrate with a substance selected from the group comprising vegetable oil, lecithin and combinations thereof.
18. The method of claim 17, wherein the vegetable oil is olive oil.
19. The method of claim 15, wherein the agricultural substrate is selected from the group comprising one or more of grains, cereals, seeds, dry fruits, herbs, spices, citrus fruits, tubers, berries, vegetables, non-legume beans and combinations thereof.
20. The method of claim 15, wherein the agricultural substrate is selected from the group comprising green coffee beans, green cocoa beans and green vanilla beans.
US13/874,832 2012-09-06 2013-05-01 Extract of a myceliated agricultural substrate and its use as a nutraceutical composition Abandoned US20140065131A1 (en)

Priority Applications (21)

Application Number Priority Date Filing Date Title
US13/874,832 US20140065131A1 (en) 2012-09-06 2013-05-01 Extract of a myceliated agricultural substrate and its use as a nutraceutical composition
CN201480028279.2A CN105228462A (en) 2013-03-15 2014-03-15 The method of the coffee product of mycelium and the coffee product for the preparation of mycelium
EP14765389.3A EP2986134B1 (en) 2013-03-15 2014-03-15 Method for making myceliated coffee products
BR112015023468-2A BR112015023468B1 (en) 2013-04-09 2014-03-15 MICELY PRODUCTS AND METHODS FOR THE PRODUCTION OF MICELY PRODUCTS FROM COCOA AND OTHER AGRICULTURAL SUBSTRATES
KR1020187019060A KR102087839B1 (en) 2013-03-15 2014-03-15 Myceliated coffee products and methods for making
KR1020157029425A KR101786644B1 (en) 2013-03-15 2014-03-15 Myceliated products and methods for making myceliated products from cacao and other agricultural substrates
BR112015023652-9A BR112015023652B1 (en) 2013-03-15 2014-03-15 method for the preparation of a mycelial coffee product and mycelial coffee product prepared by said method
PCT/US2014/029998 WO2014145265A2 (en) 2013-03-15 2014-03-15 Myceliated products and methods for making myceliated products from cacao and other agricultural substrates
EP14763975.1A EP2986159B1 (en) 2013-03-15 2014-03-15 Myceliated products and methods for making myceliated products from cacao and other agricultural substrates
PCT/US2014/029989 WO2014145256A1 (en) 2013-03-15 2014-03-15 Myceliated coffee products and methods for making
SG11201507484YA SG11201507484YA (en) 2013-03-15 2014-03-15 Myceliated products and methods for making myceliated products from cacao and other agricultural substrates
JP2016503300A JP6186070B2 (en) 2013-03-15 2014-03-15 MYCELATED COFFEE PRODUCT AND PRODUCTION METHOD
ES14763975T ES2733912T3 (en) 2013-03-15 2014-03-15 Mycelised products and methods to prepare mycelised products from cocoa and other agricultural substrates
EP19174384.8A EP3560343A1 (en) 2013-03-15 2014-03-15 Myceliated products and methods for making myceliated products from agricultural substrates
CN201480028249.1A CN105682480B (en) 2013-03-15 2014-03-15 Mycelium product and the method for preparing mycelium product by cocoa and other agricultural substrates
SG11201507655RA SG11201507655RA (en) 2013-03-15 2014-03-15 Myceliated coffee products and methods for making
JP2016503304A JP2016517280A (en) 2013-03-15 2014-03-15 Process for producing mycelia treated products and mycelia treated products from cacao and other agricultural substrates
KR1020157029417A KR20150131293A (en) 2013-03-15 2014-03-15 Myceliated coffee products and methods for making
AU2014233209A AU2014233209B2 (en) 2013-03-15 2014-03-15 Myceliated products and methods for making myceliated products from cacao and other agricultural substrates
AU2014233200A AU2014233200B2 (en) 2013-03-15 2014-03-15 Myceliated coffee products and methods for making
JP2017208402A JP6518308B2 (en) 2013-03-15 2017-10-27 Method for producing mycelium-treated products from mycelium-treated products and cocoa and other agricultural substrates

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261697506P 2012-09-06 2012-09-06
US201361802256P 2013-03-15 2013-03-15
US13/874,832 US20140065131A1 (en) 2012-09-06 2013-05-01 Extract of a myceliated agricultural substrate and its use as a nutraceutical composition

Publications (1)

Publication Number Publication Date
US20140065131A1 true US20140065131A1 (en) 2014-03-06

Family

ID=50187911

Family Applications (2)

Application Number Title Priority Date Filing Date
US13/859,719 Active US9427008B2 (en) 2012-09-06 2013-04-09 Method of myceliation of agricultural substates for producing functional foods and nutraceuticals
US13/874,832 Abandoned US20140065131A1 (en) 2012-09-06 2013-05-01 Extract of a myceliated agricultural substrate and its use as a nutraceutical composition

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US13/859,719 Active US9427008B2 (en) 2012-09-06 2013-04-09 Method of myceliation of agricultural substates for producing functional foods and nutraceuticals

Country Status (1)

Country Link
US (2) US9427008B2 (en)

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015164496A1 (en) * 2014-04-23 2015-10-29 Functional Fungi, Llc Nutritionally and botanically enhanced mycelial biomass
CN105413211A (en) * 2015-12-30 2016-03-23 天津横天生物科技有限公司 Energy-saving concentrator for powder production
WO2017181085A1 (en) 2016-04-14 2017-10-19 Mycotechnology, Inc. Methods for the production and use of myceliated high protein food compositions
EP3185700A4 (en) * 2014-08-26 2018-01-10 Mycotechnology Inc. Methods for the production and use of mycelial liquid tissue culture
CN108330072A (en) * 2018-02-02 2018-07-27 山西康欣药业有限公司 Inonotus obliquus liquid submerged fermentation culture composition and preparation method and application
CN108715870A (en) * 2018-04-19 2018-10-30 浙江理工大学 A method of improving Inonotus obliquus fermenting and producing triterpene yield
AU2017200872B2 (en) * 2014-03-10 2019-01-31 Paul Edward Stamets Integrative fungal solutions for protecting bees
US10231469B2 (en) 2014-03-15 2019-03-19 Mycotechnology, Inc. Myceliated products and methods for making myceliated products from cacao and other agricultural substrates
WO2019226759A1 (en) * 2018-05-24 2019-11-28 Mycotechnology, Inc. Method for the production and use of myceliated mixed nutrient product for enhanced nutrient supplements
CN110954642A (en) * 2018-09-26 2020-04-03 上海医药工业研究院 Detection method of grifola quality and construction method of fingerprint spectrum thereof
US10709157B2 (en) 2014-08-26 2020-07-14 Mycotechnology, Inc. Methods for the production and use of mycelial liquid tissue culture
US10806101B2 (en) 2016-04-14 2020-10-20 Mycotechnology, Inc. Methods for the production and use of myceliated high protein food compositions
US10813960B2 (en) 2000-10-04 2020-10-27 Paul Edward Stamets Integrative fungal solutions for protecting bees and overcoming colony collapse disorder (CCD)
US10980257B2 (en) 2015-02-26 2021-04-20 Myco Technology, Inc. Methods for lowering gluten content using fungal cultures
US10987389B2 (en) * 2014-05-15 2021-04-27 Xingyao LI Anti-tumor traditional Chinese medicine microbial fermentation preparation and a preparation method and application thereof
US11166477B2 (en) 2016-04-14 2021-11-09 Mycotechnology, Inc. Myceliated vegetable protein and food compositions comprising same
CN115644338A (en) * 2022-11-03 2023-01-31 湖南迪为农业科技有限公司 Lucid ganoderma health-preserving water beverage
US20230180808A1 (en) * 2018-06-08 2023-06-15 Emergy Inc. Edible compositions including fungal mycelium protein
US11752182B2 (en) 2014-03-10 2023-09-12 Turtle Bear Holdings, Llc Integrative fungal solutions for protecting bees
WO2023208970A1 (en) * 2022-04-29 2023-11-02 Nordic Umami Company Oy Fermented umami-containing enzymatically active biomass, umami concentrate, umami paste, solid umami product, salt-free or low-salt umami extract, low-salt umami product, and methods for producing the same

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011008476A1 (en) 2009-06-30 2011-01-20 3M Innovative Properties Company Cadmium-free re-emitting semiconductor construction
KR101492174B1 (en) * 2013-01-24 2015-02-10 주식회사 코시스바이오 Anti-inflammatory and immune-boosting composition containing fermented green coffee bean which is fermented with monascus
CO2017006176A1 (en) * 2017-06-21 2017-11-21 Jaramillo De Echeverri Carmenza Process for obtaining clarified oil from coffee grounds and whole and / or deteriorated beans
FR3078976B1 (en) * 2018-03-13 2023-04-14 Commissariat Energie Atomique SEQUENTIAL PROCESS FOR FUNGAL FERMENTATION OF WOOD RESOURCES
EP3827073A4 (en) * 2018-07-23 2022-05-18 Ecovative Design LLC Method of producing a mycological product and product made thereby
WO2020061502A1 (en) 2018-09-20 2020-03-26 The Better Meat Company Enhanced aerobic fermentation methods for producing edible fungal mycelium blended meats and meat analogue compositions
CN109609391B (en) * 2019-02-15 2023-03-17 福州大学 Quantitative inoculation method of mycelium pellets
CN110810513B (en) * 2019-10-30 2023-03-31 青岛农业大学 Double-fungus co-fermented aronia melanocarpa yogurt and preparation method thereof
AU2021371131A1 (en) * 2020-10-28 2023-02-02 Kinoko - Tech Ltd Food products comprising fungal mycelium, process for their preparation and uses thereof
CN112753933A (en) * 2020-12-30 2021-05-07 天津天狮学院 Functional reconstituted rice flour based on waste cordyceps militaris culture medium and preparation method thereof
SE2151489A1 (en) * 2021-12-07 2023-06-08 Mycorena Ab A food product or food ingredient comprising fungi biomass with an increased intracellular fat content
EP4331372A1 (en) 2022-09-02 2024-03-06 Justus-Liebig-Universität Gießen Preparation of beverages from by-products of aromatic plants

Family Cites Families (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1822227A (en) 1927-12-21 1931-09-08 Louise B P Lendrich Process of improving coffee-beans
US2419515A (en) 1942-12-14 1947-04-22 Phillips Petroleum Co Preparation of 1, 3-butylene glycol
US2693664A (en) 1949-08-20 1954-11-09 Szuecs Joseph Method of enhancing mushroom mycelium flavor
US3749584A (en) 1972-03-28 1973-07-31 Us Agriculture Decaffeination of beverages
US4891220A (en) 1988-07-14 1990-01-02 Immudyne, Inc. Method and composition for treating hyperlipidemia
US5934012A (en) * 1994-11-23 1999-08-10 Hps Biotechnologies, Inc. Process for production of mushroom inoculum
DK1079696T3 (en) 1998-04-17 2007-07-02 Alltech Inc Compositions for removing mycotoxins from feed
BR0009293A (en) 1999-04-23 2001-12-26 Tsukuba Biosystem Ltd Process for growing a basidiomycete fungus in a liquid culture medium
US6383799B1 (en) 1999-10-15 2002-05-07 Medmyco Ltd. Process for producing, methods and compositions of glucuronoxylomannan as nutriceutical agent from higher basidiomycetes mushroom
US6372462B2 (en) 1999-10-15 2002-04-16 Medmyco Ltd. Process for producing, methods and compositions of cholesterol lowering agents from higher basidiomycetes mushrooms
US6277396B1 (en) 2000-05-11 2001-08-21 Maximum Human Performance, Inc. Dietary supplement containing a thermogenic substance and an adrenal support substance
US6558943B1 (en) 2000-09-05 2003-05-06 Sun Ten Pharmaceutical Co., Ltd. Method for propagating fungi using solid state fermentation
US20110008384A1 (en) 2004-01-06 2011-01-13 Paul Edward Stamets Antiviral activity from medicinal mushrooms
US20140105928A1 (en) 2004-01-06 2014-04-17 Paul Edward Stamets Antiviral and antibacterial activity from medicinal mushrooms
US6660290B1 (en) 2000-10-04 2003-12-09 Myco Pesticides Llc Mycopesticides
US8765138B2 (en) 2004-01-06 2014-07-01 Paul Edward Stamets Antiviral and antibacterial activity from medicinal mushrooms
US6569475B2 (en) 2000-10-06 2003-05-27 Jae-Mahn Song Process for mycelial culture using grain
JP2002191354A (en) 2000-10-06 2002-07-09 Kabaiotekku Co Ltd Method for producing mushroom mycelium
DE10053051C2 (en) 2000-10-13 2002-10-31 Coty Bv Cosmetic preparation with plant extracts
US6476003B1 (en) 2000-11-06 2002-11-05 Immusonic, Inc. Method for preparing small particle size glucan in a dry material
WO2002065836A2 (en) 2001-02-20 2002-08-29 Paul Stamets Delivery systems for mycotechnologies, mycofiltration and mycoremediation
AT413540B (en) 2001-12-20 2006-03-15 Erber Ag MICRO-ORGANISM, WHICH EXTRACT OCHRATOXINS AND OCHRATOXINS AND ZEARALENONE, AND METHOD AND USE THEREFOR
KR20110038739A (en) 2002-06-25 2011-04-14 가부시키가이샤 아데카 β-GLUCAN-CONTAINING FAT COMPOSITIONS AND NOVEL MICROORGANISM PRODUCING Β-GLUCAN
KR100454766B1 (en) 2002-08-20 2004-11-03 주식회사 엔비텍 Biotreatment for milk-processing wastewater using mushroom's mycelia
JP2005027540A (en) 2003-07-09 2005-02-03 Ikse:Kk Agaricus blazei drink
US20050031761A1 (en) 2003-08-05 2005-02-10 Donald Brucker Methods of producing a functionalized coffee
US9867385B2 (en) 2003-09-25 2018-01-16 Suntory Beverage & Food Limited Method of processing green coffee beans
WO2005072533A1 (en) 2004-01-30 2005-08-11 Kao Corporation Coffee drink composition
JP4587442B2 (en) 2004-02-12 2010-11-24 株式会社クレハ Novel antihyperlipidemic agent and food
US7407795B2 (en) 2004-07-15 2008-08-05 John Holliday Method for growing Cordyceps sinensis on a substrate and novel method for hybridizing different strains of Cordyceps sinensis
US7514085B2 (en) * 2004-07-16 2009-04-07 Medimush A/S Immune modulating compounds from fungi
EP1835818B1 (en) 2004-12-09 2011-08-10 Eurark, LLC Product and method for producing a vehicle for oral administration of nutraceuticals
US20110081448A1 (en) 2005-01-05 2011-04-07 Firmenich Sa Process for treating vanilla beans
EP1709969A1 (en) 2005-04-07 2006-10-11 Praktijkonderzoek Plant en Omgeving B.V. Health promoting dairy and food products containing mushroom glucan produced through fermentation of Grifola frondosa
US20090104310A1 (en) 2005-05-25 2009-04-23 Toshiharu Nakajima Method of treating green coffee beans under ph regulation
US20060280753A1 (en) 2005-06-11 2006-12-14 Mcneary Peter Composition and Method For Obtaining A Nutritional Food Product Using Solid Substrate Fermentation
WO2007031186A1 (en) * 2005-09-12 2007-03-22 Vrije Universiteit Brussel Starter cultures and fermentation method
BRPI0616479A2 (en) 2005-10-05 2012-12-25 Asahi Breweries Ltd Method for producing filamentous fungus culture product, Filamentous fungus culture product, Method for producing enzyme preparation, Enzyme preparation, Method for producing enzymes by the use of liquid medium, enzymes, and, Methods for producing fermented foods and beverages. fermented foods and beverages
KR100747787B1 (en) 2006-02-23 2007-08-08 안영환 A method for manufacturing a soybean paste including pine mushroom
FI20065182A0 (en) 2006-03-20 2006-03-20 Elixi Oil Oy Fermented food
US20080107783A1 (en) * 2006-10-05 2008-05-08 Anijs Harrold G Method of producing high-brightness cocoa powder and related compositions
WO2008097482A2 (en) 2007-02-05 2008-08-14 Holliday John C Mycellated grain and other myceliated agricultural materials to be used as animal food supplement
AU2008225859B2 (en) 2007-03-09 2014-06-26 Novozymes A/S Thermostable asparaginases
JP5031508B2 (en) 2007-04-19 2012-09-19 ハウス食品株式会社 Fenugreek seed with reduced bitterness and method for producing the same
DK2139997T3 (en) 2007-04-20 2014-12-08 Dsm Ip Assets Bv Asparaginasevarianter and uses thereof
US20080274234A1 (en) 2007-05-01 2008-11-06 Carter Robert Miller Processing cocoa beans and other seeds
US20080296223A1 (en) 2007-05-30 2008-12-04 Bryan Hiromoto Bioremediation methods using fungal compositions
DE102007027825A1 (en) 2007-06-13 2008-12-18 C-Lecta Gmbh Amidohydrolases for the treatment of food or beverages
JP5475945B2 (en) 2007-11-20 2014-04-16 花王株式会社 Containerized coffee beverage
WO2009108698A2 (en) 2008-02-25 2009-09-03 University Of Florida Research Foundation, Inc. Quality enhancement of coffee beans by acid and enzyme treatment
WO2009138420A2 (en) 2008-05-15 2009-11-19 Barry Callebaut Ag Method for processing cocoa beans
JP5261576B2 (en) 2008-08-29 2013-08-14 ファービス アールアンドディー コリア カンパニー リミテッド Process for producing edible plant or edible animal and plant fermented product, edible plant or edible animal and plant fermented product, and food
FR2937866B1 (en) 2008-10-30 2010-11-26 Natura Cosmeticos Sa ANTIOXIDANT COMPLEX, COSMETIC AND PHARMACEUTICAL COMPOSITIONS COMPRISING SAID COMPLEX AND THE USE OF SAID COMPLEX
MY162227A (en) 2008-11-28 2017-05-31 Olam Int Ltd Method of washing cocoa beans to improve the quality of the cocoa products obtained from such beans
WO2010066061A1 (en) 2008-12-12 2010-06-17 Givaudan Sa Fermentation process
EP2405765A4 (en) 2009-03-11 2017-03-15 Cargill, Incorporated Process for making a cocoa product
IT1393420B1 (en) 2009-03-19 2012-04-20 Ceccarelli APPARATUS FOR COMPACTION AND DEHYDRATION OF ORGANIC WASTE
US20100239711A1 (en) 2009-03-23 2010-09-23 Pei-Jung Li Method for manufacturing coffee by solid state fermentation
SG178145A1 (en) 2009-07-29 2012-03-29 Barry Callebaut Ag Microbial composition for the fermentation of cocoa material
WO2011032244A1 (en) 2009-09-17 2011-03-24 Blazei Brazil Ltda Flours produced from fungus myceliated grain
EP2478769B8 (en) 2009-09-17 2020-08-12 Blazei Brazil LTDA Process for producing flours from fungus myceliated grain
US20110091579A1 (en) 2009-09-21 2011-04-21 Total Nutraceutical Solutions, Inc. Vitamin d2 enriched mushrooms and fungi for treatment of oxidative stress, alzheimer's disease and associated disease states
WO2011094579A2 (en) 2010-01-29 2011-08-04 New Chapter Inc. Mushroom compositions and methods for making and using
US20110206721A1 (en) 2010-02-19 2011-08-25 Vijaya Nair Fermented soy nutritional supplements including mushroom components
AU2011223445B2 (en) 2010-03-02 2015-07-16 Renaissance Bioscience Corp. Functional enhancement of microorganisms to minimize production of acrylamide
US20120100249A1 (en) 2010-04-27 2012-04-26 Dsm Ip Assets B.V. Novel asparaginase enzyme
WO2011140520A2 (en) 2010-05-07 2011-11-10 Menon & Associates Bioreactors comprising fungal strains
WO2011151831A1 (en) 2010-06-03 2011-12-08 Carmel-Haifa University Economic Corporation Ltd Extracts of cyathus striatus mushrooms, pharmaceutical compositions comprising them and a new cyathus striatus strain
US8227224B2 (en) 2010-06-09 2012-07-24 Ford Global Technologies, Llc Method of making molded part comprising mycelium coupled to mechanical device
JP2013539358A (en) 2010-07-14 2013-10-24 ネステク ソシエテ アノニム Asparaginase from basidiomycetes
ES2373852B1 (en) 2010-07-29 2012-12-18 Consejo Superrior De Investigaciones Cientificas (Csic) BIOLOGICAL DEGRADATION OF OCRATOXIN A IN ALPHA OCRATOXINE.
JP5574991B2 (en) 2011-01-07 2014-08-20 新潟麦酒株式会社 Medium for truffle cultivation and truffle mycelium
NL2008812C2 (en) 2012-05-14 2013-11-18 Ssipfeed B V ANIMAL FEED MATERIAL AND USE OF THE FEED MATERIAL.
US9068171B2 (en) 2012-09-06 2015-06-30 Mycotechnology, Inc. Method for myceliating coffee
US20140170264A1 (en) 2012-09-06 2014-06-19 Mycotechnology, Inc. Improved method for myceliating raw coffee beans including removal of chlorogenic acids
CN102860541B (en) 2012-09-07 2016-01-13 窦桂明 A kind of nothing is had a strong smell, without the preparation method of fishy smell mutton soup
WO2014145256A1 (en) 2013-03-15 2014-09-18 Mycotechnology, Inc. Myceliated coffee products and methods for making
US10231469B2 (en) 2014-03-15 2019-03-19 Mycotechnology, Inc. Myceliated products and methods for making myceliated products from cacao and other agricultural substrates
US20160120201A9 (en) 2014-03-15 2016-05-05 Mycotechnology, Inc. Myceliated Coffee Products and Methods for Making Myceliated Coffee Products
KR101487724B1 (en) 2014-06-11 2015-02-06 주식회사 알비알 Processed Brown Rice Using Fermented Rice Bran Extract and Preparing Method Thereof

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Chang et al., In vivo, 2009, Vol. 23, p. 755-760. *
Nagai et al., Food Chemistry, 2006, Vol 97, p. 256-262. *
Sone et al., Agric. Biol. Chem., 1985, Vol. 49, p. 2641-2653. *
Zhong et al. , Adv. Biochem Engin/Biotechnol., 2004, Vol. 87, p. 25-59. *

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10821145B2 (en) 2000-10-04 2020-11-03 Paul E. STAMETS Integrative fungal solutions for protecting bees
US10813960B2 (en) 2000-10-04 2020-10-27 Paul Edward Stamets Integrative fungal solutions for protecting bees and overcoming colony collapse disorder (CCD)
US11752182B2 (en) 2014-03-10 2023-09-12 Turtle Bear Holdings, Llc Integrative fungal solutions for protecting bees
AU2017200872B2 (en) * 2014-03-10 2019-01-31 Paul Edward Stamets Integrative fungal solutions for protecting bees
US10231469B2 (en) 2014-03-15 2019-03-19 Mycotechnology, Inc. Myceliated products and methods for making myceliated products from cacao and other agricultural substrates
WO2015164496A1 (en) * 2014-04-23 2015-10-29 Functional Fungi, Llc Nutritionally and botanically enhanced mycelial biomass
US10987389B2 (en) * 2014-05-15 2021-04-27 Xingyao LI Anti-tumor traditional Chinese medicine microbial fermentation preparation and a preparation method and application thereof
US10709157B2 (en) 2014-08-26 2020-07-14 Mycotechnology, Inc. Methods for the production and use of mycelial liquid tissue culture
EP3185700A4 (en) * 2014-08-26 2018-01-10 Mycotechnology Inc. Methods for the production and use of mycelial liquid tissue culture
US10980257B2 (en) 2015-02-26 2021-04-20 Myco Technology, Inc. Methods for lowering gluten content using fungal cultures
CN105413211A (en) * 2015-12-30 2016-03-23 天津横天生物科技有限公司 Energy-saving concentrator for powder production
CN109068710A (en) * 2016-04-14 2018-12-21 麦可科技有限公司 A method of for produce and using mycelium high protein foods composition
WO2017181085A1 (en) 2016-04-14 2017-10-19 Mycotechnology, Inc. Methods for the production and use of myceliated high protein food compositions
US10806101B2 (en) 2016-04-14 2020-10-20 Mycotechnology, Inc. Methods for the production and use of myceliated high protein food compositions
US11950607B2 (en) 2016-04-14 2024-04-09 Mycotechnology, Inc. Myceliated vegetable protein and food compositions comprising same
US11343978B2 (en) 2016-04-14 2022-05-31 Mycotechnology, Inc. Methods for the production and use of myceliated high protein food compositions
EP3981260A1 (en) * 2016-04-14 2022-04-13 Mycotechnology, Inc. Methods for the production and use of myceliated high protein food compositions
US10010103B2 (en) 2016-04-14 2018-07-03 Mycotechnology, Inc. Methods for the production and use of myceliated high protein food compositions
US11166477B2 (en) 2016-04-14 2021-11-09 Mycotechnology, Inc. Myceliated vegetable protein and food compositions comprising same
CN108330072A (en) * 2018-02-02 2018-07-27 山西康欣药业有限公司 Inonotus obliquus liquid submerged fermentation culture composition and preparation method and application
CN108715870A (en) * 2018-04-19 2018-10-30 浙江理工大学 A method of improving Inonotus obliquus fermenting and producing triterpene yield
WO2019226759A1 (en) * 2018-05-24 2019-11-28 Mycotechnology, Inc. Method for the production and use of myceliated mixed nutrient product for enhanced nutrient supplements
US20230180808A1 (en) * 2018-06-08 2023-06-15 Emergy Inc. Edible compositions including fungal mycelium protein
US20230180807A1 (en) * 2018-06-08 2023-06-15 Emergy Inc. Edible compositions including fungal mycelium protein
US20240099348A1 (en) * 2018-06-08 2024-03-28 Emergy Inc. Edible compositions including fungal mycelium protein
CN110954642A (en) * 2018-09-26 2020-04-03 上海医药工业研究院 Detection method of grifola quality and construction method of fingerprint spectrum thereof
WO2023208970A1 (en) * 2022-04-29 2023-11-02 Nordic Umami Company Oy Fermented umami-containing enzymatically active biomass, umami concentrate, umami paste, solid umami product, salt-free or low-salt umami extract, low-salt umami product, and methods for producing the same
CN115644338A (en) * 2022-11-03 2023-01-31 湖南迪为农业科技有限公司 Lucid ganoderma health-preserving water beverage

Also Published As

Publication number Publication date
US9427008B2 (en) 2016-08-30
US20140065263A1 (en) 2014-03-06

Similar Documents

Publication Publication Date Title
US20140065131A1 (en) Extract of a myceliated agricultural substrate and its use as a nutraceutical composition
US20200268011A1 (en) Method of myceliating coffee
KR102034835B1 (en) Methods for the production and use of mycelial liquid tissue culture
US10231469B2 (en) Myceliated products and methods for making myceliated products from cacao and other agricultural substrates
JP6518308B2 (en) Method for producing mycelium-treated products from mycelium-treated products and cocoa and other agricultural substrates
US10709157B2 (en) Methods for the production and use of mycelial liquid tissue culture
US9572364B2 (en) Methods for the production and use of mycelial liquid tissue culture
US20200352206A1 (en) Composition and method for mushroom mycelial compound and botanical mixture
US20190320596A1 (en) Nutritionally and botanically enhanced mycelial mass
US20210030044A1 (en) Methods for the Production and Use of Mycelial Liquid Tissue Culture
BR112015023468B1 (en) MICELY PRODUCTS AND METHODS FOR THE PRODUCTION OF MICELY PRODUCTS FROM COCOA AND OTHER AGRICULTURAL SUBSTRATES

Legal Events

Date Code Title Description
AS Assignment

Owner name: MYCOTECHNOLOGY, INC., COLORADO

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KELLY, BROOKS J., DR.;PHILIPS, JONATHAN FREESTONE;LANGAN, JIM;REEL/FRAME:031396/0064

Effective date: 20130530

Owner name: MYCOTECHNOLOGY, INC., COLORADO

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:MYCOTECHNOLOGY INC.;REEL/FRAME:031396/0061

Effective date: 20130823

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION

AS Assignment

Owner name: MYCOTECHNOLOGY, INC., COLORADO

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:KELLY, BROOKS JOHN;LANGAN, JAMES PATRICK;REEL/FRAME:036152/0219

Effective date: 20150710